The “In Silico Drug Safety and Efficacy” Symposium will take place in Oxford on September 21-22, 2017. This is an exciting opportunity to discuss the latest developments on in-silico assessment of drug cardiac safety and efficacy with key players across academia, industry, hospitals and regulatory agencies. Speakers will present the latest scientific advancements, and joint intersectorial efforts to accelerate the adoption of in silico methodologies for the evaluation of drug safety and efficacy. The
Symposium is supported by the NC3Rs-funded consortium and the Quantitative Systems Pharmacology network. For more information, please check here
